Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million By Reuters
Cardinal Health (CAH) agreed to buy AdaptHealth’s diabetes health business for $235 million cash and to acquire Strive Medical in a separate deal, for about $360 million total, to expand its at-Home Solutions and diabetes care. Cardinal said the deals should add to adjusted EPS within 12 months after closing. AdaptHealth and Strive Medical described their diabetes and urology-focused services.
How this was made
The 30-second read
Why it matters
The disclosed cash consideration and expected EPS accretion within 12 months make this a concrete valuation and execution catalyst, while the need for operational improvements highlights execution risk.
Market read
A new, disclosed healthcare M&A package with stated cash consideration and near-term EPS accretion expectations, plus explicit turnaround risk for the diabetes unit.
What to watch
Closing timing, reimbursement dynamics for diabetes supplies/devices, and how Cardinal integrates direct-to-patient workflows could drive realized synergy versus the stated 12-month EPS impact.
Background
Cardinal Health is expanding its at-Home Solutions business, building on its earlier purchase of Advanced Diabetes Supply, and is adding a direct-to-patient diabetes platform plus Strive’s urology and wound/ostomy offerings.
Ticker impact
Cardinal Health agreed to buy AdaptHealth’s diabetes unit and Strive Medical for about $360 million, expanding at-Home Solutions and diabetes/urology reach.
Near-term: positive deal premium and strategic rationale, but investors may discount for integration and the diabetes unit’s turnaround needs.
The article discloses deal structure and expected EPS accretion within 12 months, but also flags operational improvements needed to restore growth/profitability.
Market effects
Signals continued consolidation in home care and diabetes supply services, potentially intensifying competitive pressure on standalone diabetes device and supply providers.
Limited direct regional read-through beyond US healthcare services and home care networks.
Mostly US-focused; could influence global medtech/home-care supply chain sentiment around diabetes and urology care delivery models.
Counterpoint
The diabetes unit may require meaningful operational fixes; integration risk could outweigh near-term EPS accretion assumptions.
Key entities
- companyCardinal Health
Agreed to acquire AdaptHealth’s diabetes health business and Strive Medical for about $360 million total.
- companyAdaptHealth
Will sell its diabetes health business to Cardinal Health for $235 million cash.
- companyStrive Medical
Will be acquired by Cardinal Health, serving more than 20,000 people annually across urology, wound care, ostomy, and adult care supplies.
- analystLeerink Partners (Michael Cherny)
Called the acquisitions logical tuck-ins but noted the diabetes business needs operational improvements to restore growth and profitability.
